Quality Gaps in India's Pharma Industry: Cough...

Thiruamuthan, Assistant Editor, India Pharma Outlook

India's pharmaceutical industry, which is frequently hailed as the "pharmacy of the world," serves as a vital contributor in the delivery of reasonably priced medicines across more than 200 nations. Recent occurrences concerning defective cough syrup

Making Healthcare Affordable: GST Reforms...

Zeenat Parween, Correspondent, India Pharma Outlook

The recent GST Reform by the Government of India to exempt individual health and life insurance premiums, along with the rationalization of healthcare goods and services, marks a landmark step in its mission of achieving Affordable Healthcare and...

Oral GLP-1 Drugs: Expanding Patient Access in...

Zeenat Parween, Correspondent, India Pharma Outlook

The last ten years have seen unprecedented international momentum in GLP-1 obesity and diabetes treatment with injectable preparations changing the standard of care. The introduction of oral GLP-1 drugs is now a significant breakthrough, and it...

Top 10 Indian Ayurvedic Brands in Modernizing...

Tanuja Akkannavar, Blogger

The Top 10 Indian Ayurvedic Medicine Companies that are transforming the ancient system of Ayurvedic care into modern-day solutions. These companies not only embrace Indian culture but also demonstrate that Ayurveda is the way forward in the evolving

Pharma Compliance Software 2025 :Smarter...

Aravindan R, Correspondent, India Pharma Outlook

Pharma compliance software is significant for Pharmaceutical regulations, and it set to become newer and more complex in 2025. Many companies are adopting advanced compliance software to help streamline compliance gained by multilayered requirements

Specialty Pharmaceuticals Market: Global Trends...

Thiruamuthan T K, Correspondent, India Pharma Outlook

The global Specialty Pharmaceuticals Market is at the vanguard of healthcare innovation, stirred by cutting-edge treatments, quick development, and evolving industry trends. The global market size increased by USD 280.7 billion in 2024 and is expecte

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.